An anti-biofilm cyclic peptide targets a secreted aminopeptidase from P. aeruginosa.
Christopher John HardingMarcus BischoffMegan BergkesselClarissa Melo CzeksterPublished in: Nature chemical biology (2023)
Pseudomonas aeruginosa is an opportunistic pathogen that causes serious illness, especially in immunocompromised individuals. P. aeruginosa forms biofilms that contribute to growth and persistence in a wide range of environments. Here we investigated the aminopeptidase, P. aeruginosa aminopeptidase (PaAP) from P. aeruginosa, which is highly abundant in the biofilm matrix. PaAP is associated with biofilm development and contributes to nutrient recycling. We confirmed that post-translational processing was required for activation and PaAP is a promiscuous aminopeptidase acting on unstructured regions of peptides and proteins. Crystal structures of wild-type enzymes and variants revealed the mechanism of autoinhibition, whereby the C-terminal propeptide locks the protease-associated domain and the catalytic peptidase domain into a self-inhibited conformation. Inspired by this, we designed a highly potent small cyclic-peptide inhibitor that recapitulates the deleterious phenotype observed with a PaAP deletion variant in biofilm assays and present a path toward targeting secreted proteins in a biofilm context.
Keyphrases
- pseudomonas aeruginosa
- candida albicans
- biofilm formation
- staphylococcus aureus
- cystic fibrosis
- acinetobacter baumannii
- wild type
- drug delivery
- high throughput
- drug resistant
- molecular dynamics simulations
- copy number
- dna methylation
- single molecule
- high resolution
- extracorporeal membrane oxygenation
- anti inflammatory